The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice

Clinical Cancer Research

Volumn 8, Issue 6, 2002, Pages 1924-1931

  Miknyoczki, Sheila J ^a   Wan, Weihua ^a   Chang, Hong ^a   Dobrzanski, Pawel ^a   Ruggeri, Bruce A ^a   Dionne, Craig A ^a   Buchkovich, Karen ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; IMMUNOGLOBULIN G; NERVE GROWTH FACTOR ANTIBODY; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; NEUTRALIZING ANTIBODY; TYROSINE KINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; XENOGRAFT;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL DIVISION; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, NUDE; NERVE GROWTH FACTORS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; RABBITS; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036284490     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Structural and functional properties of the trk family of neurotrophin receptors
2. Neurotrophic factors: From structure-function studies to designing effective therapeutics
3. Neurotrophic factors and their receptors
4. Early events in neurotrophin signaling via trk and p75 receptors
5. Neurotrophin stimulation of human melanoma cell invasion: Selected enhancement of heparanase activity and heparanase degradation of specific haparan sulfate subpopulations
6. Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors
7. Role of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression
8. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling
9. Neurotrophin and trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects on in vitro invasive behavior
10. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor like protein
11. Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells
12. Nerve growth factor and the concept of neural-epithelial interactions
13. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587)
14. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines
15. Rational basis for trk inhibition therapy for prostate cancer
16. Molecular characterization of neurotrophin expression and the corresponding tropomysin receptor kinases (trks) in epithelial and stromal cells of the human prostate
17. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma
18. Expression of p75LNGFR and Trk neurotrophin receptors in normal and neoplastic human prostate
19. Neurotrophin-3 expression in human pancreatic cancers
20. Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells
21. Cellular localization of the trk neurotrophin receptor family in human non-neuronal tissues
22. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer
23. CEP-751 inhibits trk receptor tyrosine kinase activity in vitro and exhibits anti-tumor activity
24. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines
25. The trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma
26. Role of neurotrophin-trk interactions in oncology: The anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical models
27. Neutralizing anti-vascular endothelial growth factor anti-body completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo
28. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
29. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growthfactor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice
30. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy
31. Monoclonal antibodies directed to the erb-2 receptor inhibit in vivo tumour growth
32. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
33. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
34. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial-cell line and stromal cells of the human prostate
35. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines
36. Prognostic and biological role of neurotrophin-receptor trkA and trkB in neuroblastoma
37. Endogenous brain-derived neurotrophic factor and neurotrophin-3 antagonistically regulate survival of exotomized corticospinal neurons in vivo
38. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and trk tyrosine kinase inhibitors CEP-751 (KT-6587) or CEP-701 (KT-5555)
39. The neurotrophin (NT)-trk axes are an important therapeutic target in human pancreatic cancer